JIN-A02, a Mutant-Selective Fourth-Generation EGFR Inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC

Eun Ji Lee(Yonsei University), Sun Min Lim(Yonsei University)
Clinical Cancer Research
February 6, 2026
Cited by 1


Related Papers